American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

ASCO 2024 logo
  • May 31, 2024 - June 5, 2024
  • Chicago, IL, USA

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
Preliminary data from Biomica’s Phase 1 study of BMC128 will be showcased at the conference.

PRESENTATION DETAILS:
Title: Preliminary results from a First-in-Human (FIH), open-label Phase 1 study with BMC128, a rationally designed live bacterial consortium, in combination with nivolumab.
Session Type: Poster Session
Abstract Number: 8631
Date and Time: June 3, 2024, 1:30 PM – 4:30 PM (CDT)

For more information: https://conferences.asco.org/am/program

Back to all News

Highlighted News About Biomica

Microbiome Times Partnering Forum
Mar 17, 2025

Microbiome Times Partnering Forum

Biomica’s CEO, Dr. Elran Haber, is heading to Brussels this week for the Microbiome Times Partnering Forum – a key event for advancing microbiome-based therapeutics through strategic partnerships. More info & registration: www.microbiomeforum.com

Read More
Feb 27, 2025

MIXiii Health-Tech.IL 2025

Dr. Elran Haber, Biomica’s CEO, will attend MIXiii Health-Tech.IL 2025 on March 4-5 at ICC Jerusalem. This leading Israeli health-tech conference unites industry leaders, startups, and investors to explore innovations in personalized medicine, AI-driven drug development, cancer treatment, and more. More info & registration: www.mixiii.com

Read More